This profile has not been claimed and data may not be accurate.
56th percentile
Life sciences researcher turned co-founder and President building enterprise AI at CHOIR
Credibility
Domain Expertise · 67th percentile
- Research h-index of 22 across 67 works (OpenAlex).
- Identified as a researcher on OpenAlex with an h-index of 22 and 2,535 citations.
Relationship Matrix
Most Complimentary
Founder score
- 90%Probability of being accurate (90%)Borqs Technologies, where Henry Sun is a named related person, has gone public — confirmed by SEC S-1 filing and ongoing 10-K/10-Q reports.
- 90%Probability of being accurate (90%)Raised $6M per Borqs Technologies' SEC Form D filing, where Henry Sun is a named related person.
- 85%Probability of being accurate (85%)Current Co-Founder and President at CHOIR (Computers & Humans Orchestrating In Resonance), an enterprise AI company founded in 2022.
- 75%Probability of being accurate (75%)CHOIR was co-founded by a team, confirming Henry Sun had co-founders.
- 30%Probability of being accurate (30%)Identified Stack Overflow account for Henry Sun.
- 25%Probability of being accurate (25%)Research h-index of 22 across 67 works (OpenAlex).
- 25%Probability of being accurate (25%)Identified as a researcher on OpenAlex with an h-index of 22 and 2,535 citations.
What you likely need
You are an early-stage co-founder of an enterprise AI startup with a background in life sciences sales and a prior operator role at a public company. Your immediate priorities are establishing CHOIR's market credibility and securing early funding to grow beyond the current 8-person team. Leveraging your deep life sciences network and AI expertise will be key to landing your first enterprise customers.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingPursue a formal seed round for CHOIR — your operator experience at Borqs (a public company) and 23 years in life sciences sales are strong credibility signals for institutional investors focused on enterprise AI.
- positioningDouble down on life sciences as CHOIR's beachhead vertical, given your deep domain expertise at Aktana, Veeva, and Merck — enterprise AI buyers in pharma pay premium prices for proven domain knowledge.
- introsTap your former Aktana and Veeva colleagues and customers as early design partners or reference customers for CHOIR, since they already trust AI-driven commercial analytics in life sciences.
- tacticalPublish a detailed case study from one of your current CHOIR pilots (Roche, Merck, or Novartis projects listed on your profile) to build public credibility and inbound pipeline.
- hiringPrioritize hiring a technical co-founder or CTO with AI/ML engineering depth to complement your sales and general management background as CHOIR scales its product.
- positioningApply to Y Combinator or a similar accelerator — CHOIR's enterprise AI focus and your operator background are a strong fit, and the network would accelerate both fundraising and customer introductions.
- tacticalLeverage CHOIR's existing presence in China and Singapore alongside your China sales experience from Aktana to pursue Asia-Pacific enterprise contracts, a differentiated angle versus US-only AI startups.